Cardiac Arrest News and Research

Latest Cardiac Arrest News and Research

Mayo Clinic uses Arctic Front Cardiac CryoAblation Catheter system for treating AF

Mayo Clinic is the first in the U.S. to use the first minimally invasive freezing balloon technology for the treatment of atrial fibrillation approved in December by the U.S. Food and Drug Administration. The first patient received the treatment Tuesday, Jan. 4.

6 Jan 2011

Administration of therapeutic hypothermia for TBI should depend on clinical condition of individual patients

Lowering the body temperature of patients soon after they have suffered a severe brain injury may reduce neurologic complications and improve outcomes. The safety of therapeutic hypothermia for traumatic brain injury (TBI) has been demonstrated in national studies. According to a Roundtable Discussion of renowned experts in the field, when and how it is administered should depend on the clinical condition of individual patients.

5 Jan 2011

American Regent initiates voluntary recall of Sodium Bicarbonate Injection, USP 7.5% and 8.4%

American Regent is conducting a nationwide voluntary recall to the consumer and user level of ALL unexpired lots of the following products: Sodium Bicarbonate Injection, USP, 7.5%, 44.6 mEq/50 mL, Single Dose Vial

24 Dec 2010

Jury returns $7M verdict for failure to diagnose and treat cardiac tamponade in bypass surgery patient

A New York State Supreme Court Queens County jury returned a $7,000,000.00 verdict against Patrick Monteleone M.D. and Newell Robinson, M.D. where they failed to diagnose and treat cardiac tamponade (bleeding into the chest) in their patient who underwent cardiac bypass surgery on November 17, 2004.

23 Dec 2010

Merck announces FDA approval for GARDASIL against HPV-related anal cancer

Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] for the prevention of anal cancer caused by human papillomavirus (HPV) types 16 and 18 and for the prevention of anal intraepithelial neoplasia (AIN) grades 1, 2 and 3 (anal dysplasias and precancerous lesions) caused by HPV types 6, 11, 16 and 18, in males and females 9 through 26 years of age.

23 Dec 2010

Top ten advances in cardiovascular, stroke research in 2010

Research on reducing risks, improving medical treatment and improving lifestyle behaviors to fight the battle against heart disease and stroke are among the key scientific findings that make up this year's top cardiovascular and stroke research recognized by the American Heart Association/American Stroke Association.

22 Dec 2010

Cambridge Heart completes private placement

Cambridge Heart, Inc., developer of non-invasive diagnostic tests for cardiac disease, today announced that on December 20, 2010 it completed a private placement to accredited investors. The transaction raised gross proceeds of $2.9 million and consisted of Units that were comprised of one share of common stock and a warrant to purchase one share of common stock.

21 Dec 2010

Nose job gone horribly wrong

A case presented to the Southwark Coroner’s Court heard that doctors continued operating on Kelly McLure, 31, after she suffered her cardiac arrest at the private Belvedere Hospital, in Kent. The paramedics were kept waiting for 45 minutes despite insisting on taking her straight to A&E. However her surgeons Dr Edward Latimer-Sayer and Dr Ahmed el Sayed Moustafa, the anaesthetist, continued with the routine nose and chin procedure after stabilizing her.

19 Dec 2010

Second brain death exam impacts organ donation rates

Requiring a second exam on a person who is considered brain dead may be unnecessary, according to a study on the impact of a second brain death exam on organ donation rates. The research is published in the December 15, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology.

16 Dec 2010

Accidental ingestion of Tessalon could be dangerous for young children, FDA warns

The U.S. Food and Drug Administration is warning that accidental ingestion of Tessalon (benzonatate) by children younger than 10 years can result in serious side effects or death.

15 Dec 2010

ICESP selects Ekahau RTLS for staff tracking solution

Ekahau Inc., the worldwide leader in high performance Wi-Fi-based Real Time Location Systems, today announced that Ekahau RTLS is being utilized as the underlying real-time tracking and bi-directional communications technology for a staff tracking solution at Instituto do Cancer do Estado de Sao Paulo Octavio Frias de Oliveira - ICESP, part of the "Sistema FMUSP-HC" system, which is the largest public cancer treatment center in Latin America.

14 Dec 2010

Dobkin's technique delays brain damage in heart attack victims

After a heart attack and the victim stops breathing, a process of irreversible brain damage starts to occur within 3 to 4 minutes. Or does it?

8 Dec 2010

UC researchers launch clinical trial to study post-stroke brain injury

The largest clinical trial of therapeutic brain cooling after stroke has launched, led by researchers at the University of California, San Diego, the University of Texas Health Science Center at Houston, and at Cedars-Sinai Medical Center in Los Angeles. This study looks at whether hypothermia can safely be used in elderly stroke patients.

8 Dec 2010

Boston Scientific's Close the Gap campaign to raise awareness of heart disease risk factors

Boston Scientific today announced that its Close the Gap campaign is partnering with the Black Coaches and Administrators and college basketball's "The Showcase" to raise awareness of heart disease risk factors for women and minorities.

7 Dec 2010

New pilot program to honor registered organ donors

Mayor Michael R. Bloomberg and the New York Organ Donation Network today announced the launch of a new pilot program to honor the wishes of registered organ donors and help save lives.

2 Dec 2010

States struggle with significant financial budget strains, especially in Medicaid; Others position for innovative coverage efforts

Bloomberg: "U.S. states expect 'significant challenges' balancing budgets in the next two years, after closing $230 billion in gaps since 2009, as U.S. stimulus aid drops and tax receipts recover from the recession, a study said. While state spending is set to rise for the current fiscal year compared with 2010, after two straight annual declines, governments will face renewed pressure in 2012, according to the study released today by the National Governors Association. The budget period begins in July in 46 states.

2 Dec 2010

Implanted devices to treat cardiac dysfunction show success in real world use

Implanted devices that treat cardiac dysfunction in heart failure patients are as successful in "real world" use as they are in controlled clinical trial settings, according to a large new study reported in Circulation: Journal of the American Heart Association.

23 Nov 2010

Stealth Peptides introduces Bendavia clinical candidate at AHA Scientific Sessions

Stealth Peptides, a privately held biopharmaceutical company developing innovative mitochondrial therapies for diseases with significant unmet medical needs, introduced its lead clinical candidate, Bendavia, a novel compound that targets the mitochondrion, at the 2010 American Heart Association's (AHA) Scientific Sessions, Resuscitation Science Symposium.

22 Nov 2010

FDA approves new drug application for NEXTERONE Premixed Injection

Prism Pharmaceuticals, Inc. announced today that the U.S. Food & Drug Administration has approved the supplemental new drug application for NEXTERONE (amiodarone HCl) Premixed Injection, the first and only premixed intravenous (IV) bag formulation of the antiarrhythmic agent amiodarone IV.

19 Nov 2010

Gene transfer reduces and stabilizes plaque and decreases inflammation

A plaque-fighting gene - studied in various forms by researchers at the Cedars-Sinai Heart Institute for 18 years - has now been transferred intravenously to lab mice bred to model atherosclerosis (clogged arteries) in humans. Studies show the gene transfer reduced and stabilized plaque and decreased inflammation, key factors in cutting the risk of heart disease.

18 Nov 2010

Cardiac Arrest News and Research

Latest Cardiac Arrest News and Research

Mayo Clinic uses Arctic Front Cardiac CryoAblation Catheter system for treating AF

Administration of therapeutic hypothermia for TBI should depend on clinical condition of individual patients

American Regent initiates voluntary recall of Sodium Bicarbonate Injection, USP 7.5% and 8.4%

Jury returns $7M verdict for failure to diagnose and treat cardiac tamponade in bypass surgery patient

Merck announces FDA approval for GARDASIL against HPV-related anal cancer

Top ten advances in cardiovascular, stroke research in 2010

Cambridge Heart completes private placement

Nose job gone horribly wrong

Second brain death exam impacts organ donation rates

Accidental ingestion of Tessalon could be dangerous for young children, FDA warns

ICESP selects Ekahau RTLS for staff tracking solution

Dobkin's technique delays brain damage in heart attack victims

UC researchers launch clinical trial to study post-stroke brain injury

Boston Scientific's Close the Gap campaign to raise awareness of heart disease risk factors

New pilot program to honor registered organ donors

States struggle with significant financial budget strains, especially in Medicaid; Others position for innovative coverage efforts

Implanted devices to treat cardiac dysfunction show success in real world use

Stealth Peptides introduces Bendavia clinical candidate at AHA Scientific Sessions

FDA approves new drug application for NEXTERONE Premixed Injection

Gene transfer reduces and stabilizes plaque and decreases inflammation

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Cardiac Arrest News and Research

Latest Cardiac Arrest News and Research

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in